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Correction
In our publication [1], the frequencies and percentages of
lifetime and current Axis I disorders reported in Table 1
were found to be inaccurate. The values reported in Table
1 of this version have been corrected. All other outcome
variables in Table 1 were reported correctly in the original
version of the article. The analyses and results in the text
were accurate in the original version of the paper.
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Table 1: Outcome measures for individuals with CFS alone; CFS-MCS; CFS-FM; or CFS-MCS-FM
Outcome Measure CFS alone (n = 50) CFS-MCS (n = 27) CFS-FM (n = 18) CFS-MCS-FM (n = 19)
Mean (Standard Deviation)
MOS-SF-36
Physical Functioning 53.61 (25.05)a 42.50 (19.66) 40.56 (23.69) 32.89 (19.95)a
Role-Physical 4.69 (12.27) 3.85 (11.60) 4.17 (12.86) 3.95 (12.54)
Bodily Pain 49.83 (21.88)a,c 40.62 (21.63)b 30.00 (13.18)c 21.58 (18.60)a,b
General Health 36.65 (16.74)a 28.75 (15.94) 38.54 (16.62)b 19.95 (32.24)a,b
Vitality 20.73 (15.98) 15.19 (12.84) 19.72 (16.31) 11.32 (9.84)
Social Functioning 46.09 (25.15)a 30.29 (21.84)a 47.22 (23.70) 30.26 (19.68)
Role-Emotional 56.74 (45.00) 47.44 (45.39) 42.59 (35.80) 57.89 (41.34)
Mental Health 67.08 (16.30) 55.85 (19.35) 66.22 (14.79) 62.11 (18.10)
Brief COPE
Self Distraction 2.30 (0.87)a,b 2.91 (0.81)b 2.89 (0.88) 3.18 (0.65)a
Active Coping 2.97 (0.84) 3.15 (0.83) 3.28 (0.73) 3.10 (0.88)
Denial 1.41 (0.85) 1.28 (0.59) 1.25 (0.35) 1.32 (0.61)
Substance Use 1.15 (0.47) 1.22 (0.63) 1.53 (0.98) 1.24 (0.42)
Emotional Support 2.40 (0.95) 2.17 (0.91) 2.56 (0.97) 2.29 (0.85)
Instrumental Support 2.32 (0.96) 2.61 (0.93) 2.78 (0.75) 2.66 (0.99)
Behavioral Disengagement 1.33 (0.51) 1.27 (0.38) 1.47 (0.44) 1.47 (0.94)
Venting 1.93 (0.63) 2.09 (0.77) 2.39 (0.65) 2.11 (.077)
Positive Reframing 2.20 (1.06) 2.28 (0.94) 2.75 (0.96) 2.53 (1.05)
Planning 2.97 (0.97) 3.00 (0.98) 3.00 (0.86) 3.03 (0.86)
Humor 1.68 (0.79)a 1.78 (0.87) 2.39 (1.20)a 1.79 (0.77)
Acceptance 2.95 (0.88) 2.81 (0.83) 2.94 (0.75) 2.95 (0.80)
Religion 2.41 (1.01) 2.44 (0.97) 2.31 (1.06) 2.47 (1.05)
Self Blame 1.69 (0.87) 1.74 (0.75) 2.00 (0.77) 1.92 (0.79)
Beck Depression Inventory 16.47 (8.61)a 20.88 (9.64) 18.50 (9.54) 23.93 (11.43)a
Fatigue Severity Scale 5.98 (0.68) 6.35 (0.66)a 5.70 (1.22)a 6.30 (0.53)
Pittsburgh Sleep Quality Index 7.26 (2.53)a 8.69 (2.20) 8.94 (2.10) 8.95 (2.39)a
Brief Pain Inventory
Interference 2.83 (2.52)a,c,d 4.56 (2.78)b,c 5.36 (1.96)d 6.80 (2.33)a,b
Severity 3.03 (2.06)a,c 4.06 (2.02)b 4.86 (1.40)c 6.10 (2.04)a,b
Symptoms
Sore Throat 23.50 (26.61) 29.48 (26.97) 20.56 (26.40) 24.84 (28.82)
Tender Lymph Nodes 25.75 (30.36) 23.40 (26.33) 27.50 (33.79) 32.00 (27.92)
Muscle Pain 50.52 (28.34)a,b 60.76 (28.22) 72.92 (22.56)b 78.42 (24.97)a
Joint Pain 31.85 (33.25)a,c 46.04 (35.95)b 63.06 (32.18)c 75.50 (24.54)a,b
Impaired Memory 62.96 (25.22) 59.63 (23.82) 65.14 (25.53) 68.94 (22.65)
Unrefreshing Sleep 76.89 (18.89) 75.19 (25.43) 89.67 (10.86) 87.03 (14.46)
Post-Exertional Malaise 73.27 (17.84) 75.19 (19.16) 74.86 (23.74) 82.36 (14.10)
Headaches 42.91 (33.39)a 56.87 (30.50) 55.00 (31.44) 74.03 (24.39)a
Six Minute Walk Test
Distance Walked (feet) 1419.47 (312.17) 1728.08 (2387.62) 1304.28 (356.492) 1221.39 (239.23)
Average RPE 9.85 (2.24)a 10.56 (2.08) 11.37 (2.76) 11.78 (2.42)a
Sit and Reach (inches) 13.48 (3.54) 13.16 (4.49) 14.55 (4.24) 13.40 (3.77)
Hand Grip (pounds)
Right 64.45 (24.67) 61.57 (21.21) 64.19 (21.87) 52.28 (15.34)
Left 60.04 (22.71) 58.63 (17.90) 58.72 (20.71) 48.07 (17.21)
Actigraphy Mean 161.35 (58.55) 145.74 (58.13) 167.23 (48.51) 149.78 (63.12)
Lifetime Axis I Diagnosis % 29 (58.0%) 17 (63.0%) 12 (66.7%) 13 (68.4%)
Current Axis I Diagnosis % 19 (38.0%) 8 (29.6%) 9 (50.0%) 8 (42.1%)
Similar letters across diagnostic groups significantly differ at the p < .05 level.